Arecor Therapeutics (AREC) News Today → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free AREC Stock Alerts GBX 133 -3.50 (-2.56%) (As of 03:22 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArecor chief financial officer to leave in July after five yearslse.co.uk - April 23 at 7:48 AMArecor Therapeutics PLC Ordinary Shares ARECmorningstar.com - April 18 at 7:43 PMStrip Tinning shares up as hails "largest ever" glazing orderlse.co.uk - April 2 at 8:32 AMArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentfinance.yahoo.com - March 14 at 9:25 AMArecor to develop "holy grail" diabetes treatment with partner TRxlse.co.uk - March 12 at 10:31 AMARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYfinance.yahoo.com - March 12 at 10:31 AMArecor Therapeutics plc (AREC.L)finance.yahoo.com - February 16 at 4:26 PMArecor Therapeutics hails Arestat as 2023 performance "strong"lse.co.uk - February 1 at 2:28 PMArecor Therapeutics PLC Ordinary Sharesmorningstar.com - January 20 at 10:04 PMTRADING UPDATES: Patent boosts for DG Innovate and Arecor Therapeuticslse.co.uk - January 18 at 6:27 PMArecor inks co-development deal with global medical companylse.co.uk - December 4 at 3:03 PMArecor Therapeutics takes major step with first commercial sale of AT220finance.yahoo.com - November 17 at 2:43 PMTRADING UPDATES: Troy Income suspends buyback of shareslse.co.uk - November 2 at 6:41 PMArecor Therapeutics subsidiary Tetris Pharma signs deal with Goodlifelse.co.uk - September 4 at 6:30 PMArecor Therapeutics to collaborate with "top 10" pharmaceutical firmlse.co.uk - August 17 at 5:55 AMArecor Therapeutics Flags Strong 1H Progressmarketwatch.com - July 20 at 7:31 AMArecor: Business Updatefinance.yahoo.com - July 20 at 7:31 AMShareholders in Arecor Therapeutics (LON:AREC) are in the red if they invested a year agofinance.yahoo.com - June 3 at 8:21 AMArecor Therapeutics has "a strong basis to accelerate" growth strategyfinance.yahoo.com - April 24 at 9:40 AMRecent uptick might appease Arecor Therapeutics plc (LON:AREC) institutional owners after losing 16% over the past yearfinance.yahoo.com - March 14 at 3:14 AMArecor to launch second Phase I clinical trial of AT278 rapid-acting insulin for diabetes patientmsn.com - December 1 at 2:33 AMEven after rising 12% this past week, Arecor Therapeutics (LON:AREC) shareholders are still down 43% over the past yearfinance.yahoo.com - November 10 at 5:56 AMTetris Pharma Launches Ogluo® in Germanyfinance.yahoo.com - November 1 at 4:38 PMHeadline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247 demonstrate significantly accelerated insulin absorption and early exposure compared to gold standard insulins NovoLog® and Fiasp®finance.yahoo.com - October 11 at 8:49 AMArecor Therapeutics PLC (AREC)investing.com - August 24 at 9:57 PMIrish industrial output rises 8.5% in June from May, up 26% annuallylse.co.uk - August 9 at 3:17 PMArecor Therapeutics to Raise GBP6 Mln Via Discounted Placing to Buy Tetris Pharmamarketwatch.com - August 2 at 1:10 PMCompanies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In Growthfinance.yahoo.com - July 18 at 4:50 AMArecor Therapeutics Says Future Revenue-Generating Collaboration Pipeline Strongmarketwatch.com - July 16 at 12:50 AMArecor Therapeutics' (LON:AREC) investors will be pleased with their notable 57% return over the last yearfinance.yahoo.com - June 3 at 4:30 AMArecor's Sarah Howell discusses its recent webinar on the need for fast-acting insulinproactiveinvestors.com - May 31 at 2:00 PMArecor’s CEO Sarah Howell previews key diabetes webinar on Thursday 26 Marchproactiveinvestors.com - May 24 at 12:32 PMARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CAREfinance.yahoo.com - May 18 at 8:46 AMArecor Therapeutics drug has the potential to be best-in-classproactiveinvestors.com.au - April 28 at 9:36 AMArecor Therapeutics has strong pipeline of opportunities aheadproactiveinvestors.com.au - April 25 at 10:52 AMArecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for Diabetesfinance.yahoo.com - April 12 at 7:10 AMArecor scoops two awards at CambridgeshireLive Business Awardsproactiveinvestors.com - March 28 at 3:45 AMTRADING UPDATES: Arecor Therapeutics wins patent approval in USlse.co.uk - March 23 at 5:27 PMArecor Therapeutics Granted U.S. Patent for Insulin Productsmarketwatch.com - March 23 at 9:30 AMARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTSfinance.yahoo.com - March 23 at 9:30 AMArecor Therapeutics granted US patents to protect specific insulin productsproactiveinvestors.com - March 23 at 4:29 AMArecor Therapeutics Shares Jump as Vaccine Patent Is Upheld by European Patent Officemorningstar.com - October 11 at 7:48 AMSMALL CAP MOVERS: Arecor Therapeutics rockets after positive trial results; Touchstone Exploration ends drilling campaign with a bangmsn.com - September 25 at 11:07 AMSMALL CAP MOVERS: Arecor Therapeutics and Touchstone Explorationmsn.com - September 25 at 11:07 AMPortfolio Update : Correctionfinance.yahoo.com - September 24 at 7:48 AMArecor Therapeutics : Second Price Monitoring Extnmarkets.businessinsider.com - September 22 at 7:37 AMCambridge biotech makes diabetes breakthroughuk.finance.yahoo.com - September 21 at 8:02 AMArecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 ...apnews.com - September 20 at 12:01 PMArecor Announces Positive Headline Results From First Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Candidate for Diabetesfinance.yahoo.com - September 20 at 12:01 PMArecor's Insulin Candidate Achieves Positive Results in Phase 1 Trialmarketwatch.com - September 20 at 7:00 AM Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. AREC Media Mentions By Week AREC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AREC News Sentiment▼0.240.38▲Average Medical News Sentiment AREC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AREC Articles This Week▼10▲AREC Articles Average Week Get Arecor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Redx Pharma News e-therapeutics News Poolbeg Pharma News Sareum News OKYO Pharma News C4X Discovery News Hemogenyx Pharmaceuticals News Destiny Pharma News Oxford BioDynamics News Oncimmune News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AREC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
